Miguel
González Barcia
FabRx Ltd.
Ashford, Reino UnidoPublicacións en colaboración con investigadores/as de FabRx Ltd. (3)
2021
-
3D printed tacrolimus suppositories for the treatment of ulcerative colitis
Asian Journal of Pharmaceutical Sciences, Vol. 16, Núm. 1, pp. 110-119
2020
-
3D printed tacrolimus rectal formulations ameliorate colitis in an experimental animal model of inflammatory bowel disease
Biomedicines, Vol. 8, Núm. 12, pp. 1-19
2019
-
Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: First single-centre, prospective, crossover study in patients
International Journal of Pharmaceutics, Vol. 567